Seerave Foundation

The Seerave Foundation aspires to broaden and enhance the Standard of Care for cancer patients. We focus on microbiome x immune system x cancer axis

[Florey Biosciences @FloreyBio]

"In 10 years, we’ll all look back and wonder how we could let antibiotics run roughshod over our gut microbes for so long. It will be like going to a beach day and not using sunscreen to protect yourself from the sun" -@FierceBiotech exclusive on Florey https://t.co/oKDiA5QZPP

[Seerave Foundation @SeeraveF]

Great new read from @ArielleElkrief and co-authors: a timely analysis in @Nature_NPJ #PrecisionOncology showing that #antibiotics prior to chemo-immunotherapy is strongly associated with worse outcomes for lung #cancer patients. https://t.co/gDpjwTbnZp

[Seerave Foundation @SeeraveF]

How can we improve cancer patients’ lives within 5 years? We’ve explored ideas with clinicians, scientists, entrepreneurs and patient advocates from across the Seerave network. Today, we are announcing a new strategic focus on #antibiotics and #cancer. https://t.co/se8ZomQhSd

[Seerave Foundation @SeeraveF]

Watch the recordings: https://t.co/2VJ5yVCPtP

[Seerave Foundation @SeeraveF]

Experts discuss how antimicrobial resistance is an obstacle to cancer care: On April 9, the @CDC hosted an insightful panel on AMR's impact on cancer care. https://t.co/MwwWqSI0by

[Seerave Foundation @SeeraveF]

Dr. Jen Wargo from @MDAndersonNews highlighted research by @BertrandRouty, @ArielleElkrief, and Laurence Zitvogel, showing antibiotics before immune checkpoint inhibitors worsen outcomes. Thanks to the @CDC and all speakers!

[Microbiome Virtual International Forum @MicrobiomeVIF]

#MVIF #28 program is out! 🤩

⭐️ Keynote:
🇺🇸Julia Oh @jjsso0

⭐️ Short talks:
🇨🇳 Lu Wu
🇨🇳 Yiqian Duan @cocodyq
🇺🇸 Zhenrun Jerry Zhang @SZhangJerry

⭐️ Highlights:
🇨🇳 Ye Peng @YePeng21
🇯🇵 Naoki Hayashi

https://t.co/m5gFjcfYXY

[Seerave Foundation @SeeraveF]

We'll be checking out the fantastic panel assembled by @CDC_AR on how antibiotic resistance impacts cancer care, incl @JenWargoMD on how the microbiome may impact the effectiveness of immunotherapies. Apr 9 10a ET https://t.co/sitOX11nXB

[CDC Antimicrobial Resistance @CDC_AR]

Today may be #AprilFoolsDay, but #AntimicrobialResistance (AR) is no joke. AR is an urgent global public health threat. AR has the potential to affect people at any stage of life. Protect yourself & your family: https://t.co/ZD49ywc98K

[CDC Antimicrobial Resistance @CDC_AR]

Registration now open for CDC’s #AMRExchange Webinar: Impacts of #AntimicrobialResistance (AR) on #Cancer Care. The April 9 event will feature panelists discussing various aspects of how AR can affect cancer care. Register now: https://t.co/ogu6GyVwKf

[WeersmaLab @WeersmaLab]

We're very happy that this paper came out today @NatureMedicine. Exploring longitudinal dynamics of the gut microbiome in Immune Checkpoint Blockade and its relation to cancer response and side effects
@AwfulDodger @GroMicrobiome @laura_bolte @SeeraveF
https://t.co/XXW9PU1w46

[Seerave Foundation @SeeraveF]

🚀 Exciting Publication Alert! 🚀 Our grantees have just published new PRIMM cohort Data in Nature Medicine: "Longitudinal gut microbiome changes in immune checkpoint blockade in advanced melanoma." Dive into the details of this exciting study here: https://t.co/uJ1hsXcT8I

[Microbiome Virtual International Forum @MicrobiomeVIF]

SAVE THE DATE
and register for free here https://t.co/oJsHzs3PSE

[DRFZ @DRFZ_Berlin]

Prof. Dr. Hyun-Dong Chang, Leiter des Schwiete Labor für #Mikrobiota und Entzündung vom #DRFZ, als Experte zum Film am 7.2.24

[Seerave Foundation @SeeraveF]

To improve cancer patients' lives, we need to further understand immune-microbiota interactions, intratumoral microbes, diet's role & other microbiota-centered interventions using 'omics' tech. Join us in translating these innovations to benefit patients. https://t.co/o0Ao5yo8b9

[Seerave Foundation @SeeraveF]

There's a growing interest in microbiota-centered interventions. Coordinated efforts in research and translation will allow better stratification of patients and personalization of microbiota-centered interventions.

Read more here. https://t.co/KYyPM4vCoW

[Seerave Foundation @SeeraveF]

A recent @CellPressNews paper delves into the opportunities of 'omics' technology, discussing how these approaches advance our understanding of clinical actionable biomarkers for melanoma and their potential from prevention to prognosis. Read more. https://t.co/o0Ao5yo8b9

[Seerave Foundation @SeeraveF]

A recent @CellPressNews paper delves into the exciting world of 'omics' technology, discussing genomics, metabolomics, proteomics, immunomics, CHIP-omics, inflamomics, and culturomics. Discover how these approaches advance our understanding of melanoma. https://t.co/c6uLmY2leS

[Seerave Foundation @SeeraveF]

Can gut microbiota impact cancer therapies?

In our recent perspective paper in @CellPressNews, we share powerful evidence that gut microbiota mediate efficacy of anti-cancer therapies including immunotherapies such as immune checkpoint inhibitors (ICIs). https://t.co/o0Ao5yo8b9

[Seerave Foundation @SeeraveF]

Thrilled to share our latest paper in @CellPressNews: Melanoma and microbiota: Current understanding and future directions. https://t.co/k9RGmUF0tQ

Learn how the gut microbiota affects the immune and clinical response of cancer patients here. https://t.co/a4gix8k8cx

[sarah schenck @sarahspectacle]

@jfcryan @MindMicrobes @FeliceJacka @TedDinan For all you fabulous microbiome scientists and friends still in Amsterdam next week, please come see our microbe movie @InvisibleExtDoc - playing at NEMO courtesy of @SeeraveF May 23 followed by cocktails and a Q&A!